MARKET WATCH: Moderna Stock Tumbles Despite 42% Cancer Vaccine Success in Melanoma Trial...
Economy / Tech
Moderna Stock Plummets Despite Positive Cancer Vaccine Data Release...
Moderna's stock fell even though the full data, released later Thursday, appeared positive based on Wall Street expectations ahead of the release.
Read full story on US Top News and Analysis
More from Economy / Tech
Musk Pours $1B Into Skydance as Media Giant Battles Massive Debt...
Italian Truckers' Protest Costs €3M in Buffalo Mozzarella Revenue in 24 Hours...
Budget Bride: Quince Wedding Bands Cost a Third Less Than Rivals...
Beloved LA Brunch Spot Shutters After 15-Year Run...
Musk Invests $1B in Ellison's Skydance Media...
BMW's 2027 X5 Goes Both Ways: EV Boasts 450 Miles, 460kW Charging...
Musk's Broken Promise: SpaceX Share for Every American Kid Still on Hold...
Musk's Politics Cloud SpaceX-Tesla Deal Prospects, Report Says...
Sin City Gets $725M Mega-Hotel, Breaking Ground Near LA...
Gen Z Chases Crypto, Prediction Markets, But Author Says Boring Money Moves Still Win...
ITALY IN CRISIS: Truckers' Strike Triggers Food, Fuel Shortages Across South...
